IGF2BP3 and small cell lung carcinoma: To further assess the expression of hsa-miR-183, hsa-miR-182, and IGF2BP3, a total of 20 pairs of normal lung tissues (NLT) and SCLC tissues (SCLCT) were enrolled as a validation cohort.